Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin secretion by transplanted pancreatic β-cells refers to the process in which β-cells, after being transplanted (often as part of islet transplantation therapy for diabetes), sense blood glucose levels and release insulin accordingly. These cells are specialized endocrine cells located within the pancreatic islets of Langerhans and are solely responsible for producing and secreting insulin, a hormone essential for lowering blood glucose. The process involves glucose sensing, membrane depolarization, calcium influx, and insulin exocytosis, all tightly regulated to maintain glucose homeostasis. The success of transplantation depends on adequate cell mass, vascularization at the graft site, immune protection/tolerance, and preservation of intrinsic stimulus-secretion coupling mechanisms.
Glucose uptake → metabolism → ↑ATP → K_ATP channel closure → Membrane depolarization → Ca²⁺ influx → Exocytosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Secretion by Transplanted Pancreatic β-cells.